Insmed (INSM) Gross Profit (2018 - 2026)

Insmed's Gross Profit history runs 9 years deep, the most recent figure standing at $258.5 million for Q1 2026.

• In Q1 2026, Gross Profit rose 261.37% year-over-year to $258.5 million; the TTM figure through Mar 2026 stood at $670.5 million (up 130.04% YoY), while the FY2025 annual figure was $483.5 million, up 73.94% from the prior year.
• Gross Profit for Q1 2026 stood at $258.5 million, up from $219.6 million in the prior quarter.
• The five-year high for Gross Profit was $258.5 million in Q1 2026, with the low at $40.9 million in Q1 2022.
• The 5-year median for Gross Profit is $65.2 million (2023), against an average of $85.3 million.
• The sharpest annual moves came in 2022 and 2026: Gross Profit climbed 7.93% in 2022, then jumped 261.37% in 2026.
• Insmed's Gross Profit stood at $46.2 million in 2022, then jumped by 41.14% to $65.2 million in 2023, then increased by 19.99% to $78.3 million in 2024, then surged by 180.52% to $219.6 million in 2025, then increased by 17.72% to $258.5 million in 2026.
• Business Quant data shows INSM's Gross Profit at $258.5 million in Q1 2026, $219.6 million in Q4 2025, and $113.0 million in Q3 2025.